Bolus infusion of famotidine: Effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients

V. Savarino, G. S. Mela, P. Zentilin, G. Larghero, P. Cutela, M. R. Mele, A. Vassallo, C. Mansi, E. Dallorto, G. Celle

Research output: Contribution to journalArticle

Abstract

This study was carried out to assess the efficacy of intravenous (IV) famotidine in suppressing gastric secretion over a 48-hour period. Twenty postoperative patients requiring a nasogastric tube received famotidine 20 mg IV every 12 hours and gastric pH was measured continuously by means of an indwelling probe. A baseline recording was performed over the first 4 hours and then the drug was infused every 12 hours (q12h) over a 15-minute period for the subsequent 48 hours. The mean pH value achieved during each time segment under active treatment was significantly higher (P <.001) than the mean basal value. Also the density distribution of minutes spent at the various pH units confirm that famotidine is highly effective (P <.001) in raising and maintaining gastric pH above 4.0 units during most of the drug- related period (44 hours). It can be concluded that repeated intravenous boli of famotidine 20 mg every 12 hours allow us to obtain an effective control of intragastric acidity. The antisecretory action is consistent over the total 48-hour period examined and therefore the use of intermittent infusion of famotidine seems to be advisable, as opposed to the recommended continuous IV administration of cimetidine and ranitidine. There is, however, a considerable intersubject variability in the antisecretory response to the drug.

Original languageEnglish
Pages (from-to)148-152
Number of pages5
JournalJournal of Clinical Pharmacology
Volume34
Issue number2
Publication statusPublished - 1994

Fingerprint

Famotidine
Stomach
Pharmaceutical Preparations
Ranitidine
Cimetidine
Intravenous Administration

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Savarino, V., Mela, G. S., Zentilin, P., Larghero, G., Cutela, P., Mele, M. R., ... Celle, G. (1994). Bolus infusion of famotidine: Effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients. Journal of Clinical Pharmacology, 34(2), 148-152.

Bolus infusion of famotidine : Effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients. / Savarino, V.; Mela, G. S.; Zentilin, P.; Larghero, G.; Cutela, P.; Mele, M. R.; Vassallo, A.; Mansi, C.; Dallorto, E.; Celle, G.

In: Journal of Clinical Pharmacology, Vol. 34, No. 2, 1994, p. 148-152.

Research output: Contribution to journalArticle

Savarino, V, Mela, GS, Zentilin, P, Larghero, G, Cutela, P, Mele, MR, Vassallo, A, Mansi, C, Dallorto, E & Celle, G 1994, 'Bolus infusion of famotidine: Effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients', Journal of Clinical Pharmacology, vol. 34, no. 2, pp. 148-152.
Savarino, V. ; Mela, G. S. ; Zentilin, P. ; Larghero, G. ; Cutela, P. ; Mele, M. R. ; Vassallo, A. ; Mansi, C. ; Dallorto, E. ; Celle, G. / Bolus infusion of famotidine : Effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients. In: Journal of Clinical Pharmacology. 1994 ; Vol. 34, No. 2. pp. 148-152.
@article{47c6701a4c4644ee811132bcf1960989,
title = "Bolus infusion of famotidine: Effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients",
abstract = "This study was carried out to assess the efficacy of intravenous (IV) famotidine in suppressing gastric secretion over a 48-hour period. Twenty postoperative patients requiring a nasogastric tube received famotidine 20 mg IV every 12 hours and gastric pH was measured continuously by means of an indwelling probe. A baseline recording was performed over the first 4 hours and then the drug was infused every 12 hours (q12h) over a 15-minute period for the subsequent 48 hours. The mean pH value achieved during each time segment under active treatment was significantly higher (P <.001) than the mean basal value. Also the density distribution of minutes spent at the various pH units confirm that famotidine is highly effective (P <.001) in raising and maintaining gastric pH above 4.0 units during most of the drug- related period (44 hours). It can be concluded that repeated intravenous boli of famotidine 20 mg every 12 hours allow us to obtain an effective control of intragastric acidity. The antisecretory action is consistent over the total 48-hour period examined and therefore the use of intermittent infusion of famotidine seems to be advisable, as opposed to the recommended continuous IV administration of cimetidine and ranitidine. There is, however, a considerable intersubject variability in the antisecretory response to the drug.",
author = "V. Savarino and Mela, {G. S.} and P. Zentilin and G. Larghero and P. Cutela and Mele, {M. R.} and A. Vassallo and C. Mansi and E. Dallorto and G. Celle",
year = "1994",
language = "English",
volume = "34",
pages = "148--152",
journal = "Journal of Clinical Pharmacology",
issn = "0091-2700",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Bolus infusion of famotidine

T2 - Effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients

AU - Savarino, V.

AU - Mela, G. S.

AU - Zentilin, P.

AU - Larghero, G.

AU - Cutela, P.

AU - Mele, M. R.

AU - Vassallo, A.

AU - Mansi, C.

AU - Dallorto, E.

AU - Celle, G.

PY - 1994

Y1 - 1994

N2 - This study was carried out to assess the efficacy of intravenous (IV) famotidine in suppressing gastric secretion over a 48-hour period. Twenty postoperative patients requiring a nasogastric tube received famotidine 20 mg IV every 12 hours and gastric pH was measured continuously by means of an indwelling probe. A baseline recording was performed over the first 4 hours and then the drug was infused every 12 hours (q12h) over a 15-minute period for the subsequent 48 hours. The mean pH value achieved during each time segment under active treatment was significantly higher (P <.001) than the mean basal value. Also the density distribution of minutes spent at the various pH units confirm that famotidine is highly effective (P <.001) in raising and maintaining gastric pH above 4.0 units during most of the drug- related period (44 hours). It can be concluded that repeated intravenous boli of famotidine 20 mg every 12 hours allow us to obtain an effective control of intragastric acidity. The antisecretory action is consistent over the total 48-hour period examined and therefore the use of intermittent infusion of famotidine seems to be advisable, as opposed to the recommended continuous IV administration of cimetidine and ranitidine. There is, however, a considerable intersubject variability in the antisecretory response to the drug.

AB - This study was carried out to assess the efficacy of intravenous (IV) famotidine in suppressing gastric secretion over a 48-hour period. Twenty postoperative patients requiring a nasogastric tube received famotidine 20 mg IV every 12 hours and gastric pH was measured continuously by means of an indwelling probe. A baseline recording was performed over the first 4 hours and then the drug was infused every 12 hours (q12h) over a 15-minute period for the subsequent 48 hours. The mean pH value achieved during each time segment under active treatment was significantly higher (P <.001) than the mean basal value. Also the density distribution of minutes spent at the various pH units confirm that famotidine is highly effective (P <.001) in raising and maintaining gastric pH above 4.0 units during most of the drug- related period (44 hours). It can be concluded that repeated intravenous boli of famotidine 20 mg every 12 hours allow us to obtain an effective control of intragastric acidity. The antisecretory action is consistent over the total 48-hour period examined and therefore the use of intermittent infusion of famotidine seems to be advisable, as opposed to the recommended continuous IV administration of cimetidine and ranitidine. There is, however, a considerable intersubject variability in the antisecretory response to the drug.

UR - http://www.scopus.com/inward/record.url?scp=0028217487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028217487&partnerID=8YFLogxK

M3 - Article

C2 - 8163715

AN - SCOPUS:0028217487

VL - 34

SP - 148

EP - 152

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

IS - 2

ER -